Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2021-02-22 16:22 Tx date 2021-02-17 |
$HUGE
FSD Pharma Inc. |
Buyer, Stephen Earle
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
46 - Compensation for services
|
$99,999
+46,948 vol $2.13 each |
163,726 | |
Filed 2021-01-26 20:03 Tx date 2021-01-21 |
$HUGE
FSD Pharma Inc. |
Buyer, Stephen Earle
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
45,000 | |
Filed 2020-08-25 11:56 Tx date 2020-08-20 |
$HUGE
FSD Pharma Inc. |
Buyer, Stephen Earle
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
16 - Acquisition or disposition under a prospectus exemption
|
$249,999
+80,580 vol $3.10 each |
116,778 | |
Filed 2020-03-20 15:56 Tx date 2020-03-16 |
$HUGE
FSD Pharma Inc. |
Buyer, Stephen Earle
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
16 - Acquisition or disposition under a prospectus exemption
|
$49,997
+12,886 vol $3.88 each |
36,198 | |
Filed 2020-03-09 15:05 Tx date 2020-03-06 |
$HUGE
FSD Pharma Inc. |
Buyer, Stephen Earle
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
30,000 | |
Filed 2020-01-07 13:25 Tx date 2020-01-02 |
$HUGE
FSD Pharma Inc. |
Buyer, Stephen Earle
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
16 - Acquisition or disposition under a prospectus exemption
|
$49,988
+6,895 vol $7.25 each |
23,312 | |
Filed 2019-11-25 14:44 Tx date 2019-11-07 |
$HUGE
FSD Pharma Inc. |
Buyer, Stephen Earle
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
15,000 | |
Filed 2019-11-25 14:43 Tx date 2019-10-11 |
$HUGE
FSD Pharma Inc. |
Buyer, Stephen Earle
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-11-25 14:28 Tx date 2019-10-16 |
$HUGE
FSD Pharma Inc. |
Buyer, Stephen Earle
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
37 - Stock split or consolidation
|
-3,283,583 vol |
16,417 | |
Filed 2019-11-25 14:26 Tx date 2019-10-11 |
$HUGE
FSD Pharma Inc. |
Buyer, Stephen Earle
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares Class B
00 - Opening Balance-Initial SEDI Report
|
3,300,000 |